Disparities and Trends in Brachytherapy Utilization by Race for Patients with Breast and Prostate Cancer

Algan, Özer; Algan, Sheila; Herman, Terence S.

doi:10.1016/j.brachy.2017.04.066

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This study also found that African American women were less likely to receive radiation therapy after BCT compared to Caucasian women. This decrease in radiation therapy is not just seen in breast cancer, but also in patients with prostate cancer with both studies showing a greater disparity in minority groups [9]. Observational studies show that receiving BCT without radiation therapy decreases survival [10].…”

Section: Introductionmentioning

confidence: 96%

A National Cancer Database Study on Intra-Operative Radiation Therapy in Breast Cancer Patients: Does Socioeconomic Status or Race Correlate with Cure?

Son¹,

Mulder²,

Madrigrano³

2018

Surgery Curr Res

View full text Add to dashboard Cite

Background: Minority women with breast cancer more commonly have poorer outcomes and survival rates. Disparities are multifactorial. It is possible that poor outcomes in minority groups are related to aspects of care such as Intra-Operative Radiation Therapy (IORT). Our study aims to explore whether minority groups who received IORT vs. External Beam Radiation Therapy (EBRT) have poorer outcomes in comparison to non-minorities. Methods:A retrospective review of data from the National Cancer Database (NCDB) from 2004-2015 was conducted on breast cancer patients who received IORT and EBRT. Multiple demographic variables were examined. Outcomes variables included readmission within 30 days, 30-day mortality, 90-day mortality, and long term survival. Results:Patients who underwent IORT were generally older than those who underwent non-IORT radiation (66 years of age versus 60; p<0.001). Fewer black patients underwent IORT compared to white patients (p<0.001). There was no significant difference between patients who underwent IORT and those who underwent non-IORT radiation on 30-day or 90-day mortality, (p>0.99 and p=0.45, respectively).

show abstract

Section: Introductionmentioning

confidence: 96%